Drug Shortage Report for INHIBACE PLUS
Report ID | 230712 |
Drug Identification Number | 02181479 |
Brand name | INHIBACE PLUS |
Common or Proper name | Hydrochlorothiazide / Cilazapril |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE CILAZAPRIL |
Strength(s) | 12.5MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 28 tablets |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-07-01 |
Actual start date | |
Estimated end date | 2024-10-20 |
Actual end date | 2024-10-18 |
Shortage status | Resolved |
Updated date | 2024-10-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-10-19 | English | Compare |
v8 | 2024-10-18 | French | Compare |
v7 | 2024-10-18 | English | Compare |
v6 | 2024-09-16 | French | Compare |
v5 | 2024-09-16 | English | Compare |
v4 | 2024-07-02 | English | Compare |
v3 | 2024-06-17 | French | Compare |
v2 | 2024-06-17 | English | Compare |
v1 | 2024-06-17 | English | Compare |
Showing 1 to 9 of 9